Abstract
The cell-free culture filtrate (CCF) was prepared from a culture of an Aspergillus flavus antagonist, Bacillus subtilis B-FS06. The CCF inhibited the growth and spore germination of A. flavus at a series of concentrations (10, 25, 50%) (v/v). It still retained the activity after treatment at pH values ranging from 2 to 12 for 24 h or at 100 °C for 30 min. The antifungal activity, however, was reduced by 30% after treatment at 121 °C for 20 min. After purification by anion exchange chromatography, gel filtration chromatography and HPLC, the active compounds revealed six ion peaks: [M–H] m/z = 1006.78, 1020.71, 1034.74, 1049.54, 1056.78, and 1071.64 by using electrospray ionization mass spectrometry (ESI-MS) analysis. In the presence of the active compounds at 200 μg/g, the growth of A. flavus on peanuts was completely inhibited.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Aspergillus flavus is one of the major spoilage organisms of intermediate moisture foods (Nielsen and Rios 2000; Batista et al. 2003; González et al. 2005). It is notable for the secondary metabolites (aflatoxins) that are potent hepatotoxins and carcinogens (Cullen and Newberne 1994; Roebuck and Maxuitenko 1994). Aflatoxins were designated as human liver carcinogens in 1993. Besides producing aflatoxins, A. flavus is also a human pathogen causing aspergillosis and onychomycosis (Tendolkar et al. 2005; Zhang et al. 2005; Mahmoudabadi and Zarrin 2005). Of the many research approaches being used to reduce and, ultimately, eliminate A. flavus contamination, biological control is one of the more promising techniques, particularly for the near-term (Norner 2004).
Numerous bacteria have been tested for biological control of A. flavus. Cuero et al. (1987) investigated the interaction between A. flavus and Hyphopichia burtonii or Bacillus amyloliquefaciens in the laboratory, which indicated that temperature and water activity played key roles in determining whether these two bacteria act as inhibitors or stimulators on the growth and aflatoxin production of A. flavus. Kimura and Hirano (1988) isolated a B. subtilis strain NK-330 that could inhibit the growth and aflatoxin production of A. flavus. Misaghi et al. (1995) screened a Pseudomonas cepacia (D1) strain from 892 bacterial isolates, which suggested that the bacterium significantly reduced the damage of A. flavus to cotton locules when D1 was inoculated with A. flavus simultaneously in field studies. Bueno et al. (2006) determined the effects of two species of lactobacilli, Lactobacillus casei CRL 431 and L. rhamnosus CRL 1224, on the growth of different A. flavus strains. The results indicated that L. casei CRL 431 and L. rhamnosus CRL 1224 might be utilized as potential biocontrol agents against A. flavus. Some other bacterial species had been found to be able to reduce A. flavus growth and/or aflatoxin production significantly (Mickler et al. 1995; Misaghi et al. 1995; Bluma and Etcheverry 2006; Palumbo et al. 2006).
It is not feasible by using bacteria for direct biological control under any conditions. In this case, biorational control, the direct use of active compounds rather than bacteria, is an attractive alternative control strategy (Klich et al. 1993). However, few studies have been performed on the identification of inhibitory bacterial metabolites against the growth of A. flavus and/or aflatoxin production. The cell-free supernatant of Lactococcus lactis subsp. lactis CHD-28.3 (Roy et al. 1996) and the culture supernatant and lysate of Salmonella typhi and Escherichia coli (Yadav et al. 2005) exhibited the activities against A. flavus. The active compounds, however, have not yet been purified and/or identified. Only bacillomycin D, a lipopeptide from Bacillus subtilis AU195, was found to inhibit the growth of A. flavus (Moyne et al. 2001). During the screening of bacteria for antagonistic activity against A. flavus in vitro, we identified a Bacillus subtilis isolate, B-FS06 with high antifungal activity (Zhang et al. 2007).
The purpose of this study was to identify the influence of the cell-free culture filtrate (CCF) on the mycelial mass and spore germination of A. flavus, and to isolate, purify and characterize the antifungal compound(s) secreted by B. subtilis B-FS06.
Materials and methods
Microorganisms
Bacterial antagonist, strain B-FS06, was isolated from a rape field and identified as Bacillus subtilis (Zhang et al. 2007). The strain was stored on nutrient agar (NA) (1% peptone, 0.3% beef extract, 0.5% NaCl, 1.5% agar, pH 7.0) slants at 4 °C. A. flavus CGMCC 3.2890 was provided by the China General Microbiological Culture Collection Center (CGMCC). Potato dextrose agar (PDA) medium (20% potato extract, 2% dextrose, 1.5% agar) slants were used to store the fungus at 4 °C.
Preparation of CCF
The B-FS06 strain was activated in 3 mL nutrient broth (NB) medium (1% peptone, 0.3% beef extract, 0.5% NaCl, pH 7.0) on a constant temperature shaker (30 °C, 120 rev/min) for 8 h. The broth was transferred to 2,000 mL fresh NB and incubated at 30 °C, 120 rev/min for 48 h and centrifuged at 1,000g for 20 min at 4 °C. The supernatant was concentrated to five times of the original concentration by using polyethylene glycol 6000 and filtered through a 0.45 μm pore size filter to yield the CCF. It was stored at −20 °C.
In vitro antifungal activity
Agar well diffusion assay was used for the detection of antifungal activity. PDA plates containing 104 A. flavus spores per mL were prepared. A well with a diameter of 6 mm was then cut in the agar using a sterile cork-borer. A droplet of agar was added to the well in order to seal it to avoid leakage. Then, 100 μL of CCF was added into the well and allowed to diffuse into the agar during a 5-h pre-incubation period at room temperature, followed by aerobic incubation at 30 °C for 24 h. The antifungal zone was recorded.
Inhibition of fungal mycelium by CCF
CCF was added to autoclaved and pre-cooled potato dextrose broth (PDB) in 100-mL flasks at concentrations of 50, 25, 10% (v/v) to a final volume of 30 mL. The control flask was used without CCF. Each treatment flask was inoculated separately in triplicate with 10 μL of A. flavus spores suspension containing 1 × 105 spores. Flasks were incubated at 30 °C in a shaking incubator at 150 rev/min. Mycelium was harvested after 5 days, freeze-dried, and the mycelial weight was recorded.
Spore germination inhibition assay
The inhibitory effect of CCF against spore germination of A. flavus was tested in microtiter plates. Each well contained 90 μL mixture (PDB mixed with the CCF and sterile water), and then 10 μL spore suspension containing 1 × 104 spores was added into the well. The final concentrations (v/v) of CCF were 0, 10, 25, and 50% respectively. The slides were placed in humid chambers in triplicate and incubated in the dark at 30 °C for 8 h. Immediately after incubation, a drop of lactophenol cotton blue (40 mL of glycerol, 20 mL of lactic acid, 20 g of phenol, and 5 mL of 1% aqueous cotton blue) was added to each slide to prevent further growth and then the number of germinated and non-germinated spores was counted under a light microscope (Nikon YS100, Tokyo, Japan). In each replication, 100 spores were observed, and the percentage of spore germination was then calculated.
Stability of CCF
In order to test the stability of CCF at different temperatures, the samples of CCF were exposed at 20, 40, 60, 80, 100 °C for 30 min or 121 °C for 20 min. The remaining antifungal activities were assayed after the solutions had cooled to room temperature. In order to test the stability of CCF under acid and alkaline conditions, CCF samples were adjusted to pH 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12.0 using 0.5 M HCl or NaOH, and maintained at room temperature for 24 h. After the pH had been readjusted to 7.0, the remaining anti-Aspergillus activities were determined. The antifungal activities were tested by using the agar well diffusion assay.
Isolation of the antifungal compound
The pH of the CCF was adjusted to 2 with concentrated HCl. After centrifugation at 1,300g for 20 min at 4 °C, the precipitate was extracted twice with five times volume of methanol. The crude extract was dissolved in 50 mM Tris–HCl, pH 7.5 buffer after evaporation of the methanol. The solution was loaded onto a Cellulose DE52 (1.6 × 15 cm) column equilibrated with 50 mM Tris–HCl, pH 7.5 buffer which containing 50 mM NaCl. The column was washed with 150 mL of the same buffer and then with 150 mL of a linear 0.05–1 M NaCl gradient at a flow rate of 1 mL/min. The outflow was monitored by absorbance at 280 nm. The antifungal fraction was then applied to a Sephadex G-100 (1.5 × 80 cm) column which had been equilibrated with distilled water and eluted with distilled water at a flow rate of 0.8 mL/min. The antifungal fraction was collected and concentrated. Further purification was carried out by RP-HPLC with a C18 column (COSMOSIL 5C18-AR-300, 4.6 × 250 mm, Waters) on Agilent 1100 and monitored by absorbance at 215 nm. Elution (0.8 mL/min) was performed with 40% methanol in water during 0–10 min, a linear gradient from 40% methanol in water to 95% during 10–40 min. 95% methanol in water during 40–50 min. The major peaks were collected manually and subsequently tested for antagonistic activity against A. flavus.
Identification by mass spectrometry
Electrospray ionization mass spectrometry (ESI-MS) analysis was performed on a Finnigan TSQ Quantum ultra triple quadrupole mass spectrometer (Thermo Electron Corporation, San Jose, California, USA) to determine the molecular weight of the antifungal compounds. The TSQ Quantum Ultra was operated with negative ionization mode, electrospray voltage set at 5,000 V and ion transfer tube temperature at 350 °C.
Antifungal activity of the compounds on peanuts
The compounds were freeze-dried and weighed, and then were dissolved in 50 mM Tris–HCl, pH 7.5. Peanuts were surface sterilized with 1% NaOCl solution and rinsed in three successive changes of sterile distilled water. Fifteen grams of peanuts were distributed in each of 100 mL conical flasks and 2 mL of each concentration of compounds was added to each flask. For the control, 2 mL 50 mM Tris–HCl (pH 7.5) was added to 15 g peanuts in conical flasks. The flasks were kept for 24 h with thorough agitation so that all the solution could be absorbed by peanuts. The flasks were then inoculated in triplicate for each concentration with 100 μL of A. flavus spore suspension (1 × 104). After incubation at 30 °C for 5 days with vigorous shaking for 5 min daily, the growth of A. flavus was evaluated macroscopically.
Results
Effect of CCF on mycelial weight and spore germination
The experiment of the mycelial weight inhibition by CCF was determined after 120 h of incubation. Mycelia were freeze-dried and weighed. Compared with black control, there was a significant reduction in the weight of fungal mycelia in the presence of CCF, which reduced by more than 50% when the concentration of CCF attained 25%.
In order to determine the inhibitory effect of CCF on spore germination, A. flavus spores were inoculated in microtiter plates in the present of CCF. After incubation for 8 h, the percentage of spore germination was calculated. Our data suggested that CCF also inhibited spore germination. Compared with control (without CCF), spore germination rate reduced by more than 40% by 25% of CCF.
Effect of temperature and pH on CCF
After exposure at different temperatures and pH values, the CCF was stable enough for routine laboratory studies. No activity loss was observed after the incubation of CCF at 20–100 °C for 30 min. However, the activity reduced by 30% when the CCF was autoclaved at 121 °C for 20 min. The activity of CCF was not affected at pH 2 through 12.0 after incubation at room temperature for 24 h.
Purification of the active compounds
The HCl precipitate of the B. subtilis B-FS06 CCF was extracted with methanol. After removal of methanol, crude extract was dissolved in 50 mM Tris–HCl buffer, pH 7.5 and passed through a cellulose DE52 anion-exchange column (Fig. 1A). All the peaks were collected as separate fractions, and the peak eluting at 220 through 250 min showed antifungal activity. The fraction with anti-Aspergillus activity was then purified on a Sephadex G-100 gel filtration column (Fig. 1B). Two peaks were obtained and the first peak showed the antifungal activity. RP-HPLC was performed for further purification of active compounds (Fig. 1C). The major peak (40 min) collected manually showed strong antifungal activity.
Mass spectrometry analysis
Mass spectrometry was utilized to identify the antifungal compounds. The mass spectrum (Fig. 2) revealed six ion peaks: [M–H] m/z = 1006.78, 1020.71, 1034.74, 1049.54, 1056.78 and 1071.64. The peak [M–H] m/z = 1071.64 had the highest relative abundance.
Inhibitory activity in vivo
The contamination of A. flavus on peanuts was examined after incubation for 5 days in the presence of active compounds (Fig. 3). The growth of A. flavus decreased with the increase of the active compounds concentration. Compared with the blank control, 100 μg/g of active compounds significantly reduced mycelial growth, and the growth of A. flavus was completely inhibited at 200 and 250 μg/g of compounds.
Discussion
To search for antifungal compounds with high activity against A. flavus, B. subtilis B-FS06 was isolated with antagonistic activity against A. flavus (Zhang et al. 2007). The CCF of B. subtilis B-FS06 significantly inhibited the growth and spore germination of A. flavus, and its antifungal compound is very heat stable and insensitive to pH. Of the two propagules, A. flavus spores are most ubiquitous as agents of reproduction, dispersal and/or survival, and hence have the largest dispersal scope and potential of infecting plant species and contaminating food and feed. Since germination is the starting event of the asexual life cycle of this fungus, antifungal compounds from B. subtilis B-FS06 should feasibly prevent germination of this fungus. Furthermore, purified compounds could inhibit the growth of A. flavus on peanuts, which indicated that the compounds had the potential as additive applied in food storage.
Chromatographic analysis of the HCl precipitate from B-FS06 showed that the antifungal compounds were proteins. Furthermore, mass spectrum analysis revealed six peaks with m/z between 1000 and 1100. Most of the antifungal peptides secreted by B. subtilis have a molecular weight of less than 2,000 Da and belong to cyclic lipopeptides with a peptide moiety and a fatty acid linked to the constituent amino acid residues. Intervals of 14 are often observed for molecular weight of these cyclic lipopeptides with different numbers of methylene groups (–CH2–) in fatty acylchains. These antifungal compounds were separated from two series of ion peaks: [M–H] m/z = 1006.78, 1020.71, 1034.74, 1049.54 and [M–H] m/z = 1056.78, 1071.64 according to their m/z. The two series of peaks were highly similar to surfactin and bacillomycin D homologues respectively, by comparing with their mass data with those obtained in previous studies (Kowall et al. 1998; Koumoutsi et al. 2004; Moyne et al. 2001). Surfactin and bacillomycin D are lipopeptide biosurfactants produced by B. subtilis. Surfactin has hemolytic (Kracht et al. 1999), antiviral (Kracht et al. 1999; Vollenbroich et al. 1997), antibacterial (Heerklotz and Seelig 2001) and antitumor (Kameda 1974) properties, while bacillomycin D has antitumor (Oleinikova et al. 2005), hemolytic (Oleinikova et al. 2005) and antifungal (Moyne et al. 2001) activities. Compared with previous studies, we suggest that the bacillomycin-like compounds are responsible for the anti-Aspergillus activity.
Bacillomycin D belongs to the iturin group. Iturin is a group of cyclic lipopeptides including iturin A, C, D, bacillomycin D, F, L and mycosubtilin (Maget-Dana and Peypoux 1994). Ono and Kimura (1991) reported that iturin A could inhibit aflatoxin production by A. flavus, but later iturin A was described not to be able to inhibit A. flavus growth and aflatoxin production (Klich et al. 1993; Moyne et al. 2001). Moyne et al. (2001) purified two bacillomycin D analogues (masses of 1,044 and 1,058 Da) with inhibitory activity of A. flavus from B. subtilis AU195. In this paper, we purified bacillomycin-like compounds with masses of 1,058 and 1,072 Da, which indicated one methylene group (–CH2–) in the fatty acyl chain more than that which Moyne et al. (2001) described. The biological activity of iturin depends on the composition of the length of the lipid chain. The longer the lipid chain length, the greater the antifungal activity of iturin (Maget-Dana and Peypoux 1994). This suggests that B-FS06 has a stronger antifungal activity than B. subtilis AU195.
Conclusion
In conclusion, bacillomycin-like compounds were purified and identified according to its anti-Aspergillus activity. A. flavus occurs widely during intermediate moisture food storage. Because of their activity against A. flavus, the compounds may be useful as potential biocontrol agents against A. flavus during food storage.
References
Batista LR, Chalfoun SM, Prado G, Schwan RF, Wheals AE (2003) Toxigenic fungi associated with processed (green) coffee beans (Coffea arabica L.). Int J Food Microbiol 85:293–300
Bluma RV, Etcheverry MG (2006) Influence of Bacillus spp. isolated from maize agroecosystem on growth and aflatoxin B1 production by Aspergillus section Flavi. Pest Manag Sci 62:242–251
Bueno DJ, Siva JO, Oliver G, González SN (2006) Lactobacillus casei CRL 431 and Lactobacillus rhamnosus CRL 1224 as biological controls for Aspergillus flavus strains. J Food Prot 69:2544–2566
Cuero RG, Smith JE, Lacey J (1987) Stimulation by Hyphopichia burtonii and Bacillus amyloliquefaciens of aflatoxin production by Aspergillus flavus in irradiated maize and rice grains. Appl Environ Microbiol 53:1142–1146
Cullen JM, Newberne PM (1994) Acute hepatoxicity of aflatoxins. In: Eaton DL, Groopman JD (eds) The toxicology of aflatoxins. Academic Press, San Diego, pp 3–26
González G, Hinojo MJ, Mateo R, Medina A, Jiménez M (2005) Occurrence of mycotoxin producing fungi in bee pollen. Int J Food Microbiol 105:1–9
Heerklotz H, Seelig J (2001) Detergent-like action of the antibiotic peptide surfactin on lipid membranes. Biophys J 81:1547–1554
Kameda Y, Oira S, Matsui K, Kanatomo S, Hase T (1974) Antitumor activity of Bacillus natto. V. Isolation and characterization of surfactin in the culture medium of Bacillus natto KMD 2311. Chem Pharm Bull 22:938–944
Kimura N, Hirano S (1988) Inhibitory strains of Bacillus subtilis for growth and aflatoxin-production of aflatoxigenic fungi. Agric Biol Chem 52:1173–1179
Klich MA, Lax AR, Bland JM, Scharfenstein LL Jr (1993) Influence of iturin A on mycelial weight and aflatoxin production by Aspergillus flavus and Aspergillus parasiticus in shake culture. Mycopathologia 123:35–38
Koumoutsi A, Chen XH, Henne A, Liesegang H, Hitzeroth G, Franke P, Vater J, Borriss R (2004) Structural and functional characterization of gene clusters directing nonribosomal synthesis of bioactive cyclic lipopeptides in Bacillus amyloliquefaciens strain FZB42. J Bacteriol 186:1084–1096
Kowall M, Vater J, Kluge B, Stein T, Frank P, Ziessow D (1998) Separation and characterization of surfactin isoforms produced by Bacillus subtilis OKB 105. J Colloid Interface Sci 204:1–8
Kracht M, Rokos H, Ozel M, Kowall M, Pauli G, Vater J (1999) Antiviral and hemolytic activities of surfactin isoforms and their methyl ester derivatives. J Antibiot 52:613–619
Maget-Dana R, Peypoux F (1994) Iturins, a special class of pore-forming lipopeptides: biological and physicochemical properties. Toxicology 87:151–174
Mahmoudabadi AZ, Zarrin M (2005) Onychomycosis with Aspergillus flavus; a case report from Iran. Pak J Med Sci 21:497–498
Mickler CJ, Bowen KL, Kloepper JW (1995) Evaluation of selected geocarposphere bacteria for biological control of Aspergillus flavus in peanut. Plant Soil 175:291–299
Misaghi IJ, Cotty PJ, Decianne DM (1995) Bacterial antagonists of Aspergillus flavus. Biocontrol Sci Technol 5:387–392
Moyne AL, Shelby R, Cleveland TE, Tuzun S (2001) Bacillomycin D: an iturin with antifungal activity against Aspergillus flavus. J Appl Microbiol 90:622–629
Nielsen PV, Rios R (2000) Inhibition of fungal growth on bread by volatile components from spices and herbs, and possible application in active packaging, with special emphasis on mustard essential oil. Int J Food Microbiol 60:219–229
Norner JW (2004) Biological control of aflatoxin contamination of crops. J Toxicol 23:425–450
Oleinikova GK, Dmitrenok AS, Voinow VG, Chaikina EL, Shevchenko LS, Kuznetsova TA (2005) Bacillomycin D from the marine isolate of Bacillus subtilis KMM 1992. Chem Nat Compd 41:461–464
Ono M, Kimura N (1991) Antifungal peptides produced by Bacillus subtilis for the biological control of aflatoxin contamination Proc Jpn Assoc Mycotoxicol 34:23–28
Palumbo JD, Baker JL, Mahoney NE (2006) Isolation of bacterial antagonists of Aspergillus flavus from almonds. Microb Ecol 52:45–52
Roebuck BD, Maxuitenko YY (1994) Biochemical mechanisms and biological implications of the toxicity of aflatoxins as related to aflatoxin carcinogenesis. In: Eaton DL, Groopman JD (eds) The toxicology of aflatoxins. Academic Press, San Diego, pp 27–43
Roy U, Batish VK, Grover S, Neelakantan S (1996) Production of antifungal substance by Lactococcus lactis subsp. lactis CHD-28.3. Int J Food Microbiol 32:27–34
Tendolkar U, Sharma A, Mathur M, Ranadive N, Sachdev M (2005) Epidural mass due to Aspergillus flavus causing spinal cord compression-a case report and brief update. Indian J Med Microbiol 23:200–203
Vollenbroich D, Ozel M, Vater J, Kamp RM, Pauli G (1997) Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis. Biologicals 25:289–297
Yadav V, Gupta J, Mandhan R, Chhillar AK, Dabur R, Singh DD, Sharma GL (2005) Investigations on anti-Aspergillus properties of bacterial products. Lett Appl Microbiol 41:309–314
Zhang Q, Li L, Zhu M, Zhang C, Wang J (2005) Primary cutaneous aspergillosis due to Aspergillus flavus: a case report. Chin Med J 118:255–257
Zhang T, Hu LB, Wang F, Cheng LG, Shi ZQ (2007) Identification of B-FS06 and the antagonistic activity of its cultural productions against Aspergillus flavus. Chin J Biol Control 23:160–165
Author information
Authors and Affiliations
Corresponding author
Additional information
Ting Zhang and Zhi-Qi Shi contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhang, T., Shi, ZQ., Hu, LB. et al. Antifungal compounds from Bacillus subtilis B-FS06 inhibiting the growth of Aspergillus flavus . World J Microbiol Biotechnol 24, 783–788 (2008). https://doi.org/10.1007/s11274-007-9533-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11274-007-9533-1